Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C9H11IN2O5 |
Molecular Weight | 354.0985 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(I)C(=O)NC2=O
InChI
InChIKey=XQFRJNBWHJMXHO-RRKCRQDMSA-N
InChI=1S/C9H11IN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1
Molecular Formula | C9H11IN2O5 |
Molecular Weight | 354.0985 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:08:13 UTC 2023
by
admin
on
Fri Dec 15 15:08:13 UTC 2023
|
Record UNII |
LGP81V5245
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1557
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
||
|
WHO-VATC |
QJ05AB02
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
||
|
WHO-ATC |
S01AD01
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
||
|
WHO-ATC |
J05AB02
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
||
|
NDF-RT |
N0000175466
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
||
|
WHO-ATC |
D06BB01
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
||
|
NCI_THESAURUS |
C281
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
||
|
NDF-RT |
N0000175459
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
||
|
FDA ORPHAN DRUG |
95696
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
||
|
WHO-VATC |
QS01AD01
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
||
|
WHO-VATC |
QD06BB01
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
39661
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
100000083677
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
1486
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
IDOXURIDINE
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | Description: A white or almost white, crystalline powder. Solubility: Slightly soluble in water, ethanol (~750 g/l) TS and hydrochloric acid (~70 g/l) TS; freely soluble in sodium hydroxide(~80 g/l) TS. Category: Anti-infective agent. Storage: Idoxuridine should be kept in a well-closed container, protected from light. Labeling: The designation Idoxuridine for sterile non-injectable use indicates that the substance complies with the additional requirement and may be used for sterile applications. Expiry date.Additional information: Melting temperature, about 180?C, with decomposition. Requirement: Idoxuridine contains not less than 98.0% and not more than 101.0% of C9H11IN2O5, calculated with reference to the dried substance. | ||
|
LGP81V5245
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
DTXSID2045238
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
LGP81V5245
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
DB00249
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
7479
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
5905
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
D007065
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
1417
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
m6201
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | Merck Index | ||
|
200-207-8
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
SUB08117MIG
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
1336001
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
147675
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
5653
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | RxNorm | ||
|
54-42-2
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
C563
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
CHEMBL788
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY | |||
|
IDOXURIDINE
Created by
admin on Fri Dec 15 15:08:13 UTC 2023 , Edited by admin on Fri Dec 15 15:08:13 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SOLVATE->ANHYDROUS |
|
||
|
LABELED -> NON-LABELED |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
LABELED -> NON-LABELED |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
PRODRUG -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|